Preparation and evaluation of glycosylated arginine-glycine-aspartate (RGD) derivatives for integrin targeting
B. Kuijpers, S. Groothuys, A. Soede, P. Laverman, O. Boerman, F. van Delft and F. RutjesArticles
Bioconjug Chem
2007
1847--1854
Diagnostic value of asymmetric striatal D2 receptor upregulation in Parkinson's disease: an [123I]IBZM and [123I]FP-CIT SPECT study
C. Verstappen, B. Bloem, C. Haaxma, W. Oyen and M. HorstinkArticles
EJNMMI
2007
502--507
Development and application of peptide-based radiopharmaceuticals
I. Dijkgraaf, O. Boerman, W. Oyen, F. Corstens and M. GotthardtArticles
Anticancer Agents Med Chem
2007
543--551
Software package for integrated data processing for internal dose assessment in nuclear medicine (SPRIND)
E. Visser, E. Postema, O. Boerman, J. Visschers, W. Oyen and F. CorstensArticles
EJNMMI
2007
413--421
Alpha v beta 3 integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide
I. Dijkgraaf, J. Kruijtzer, C. Frielink, F. Corstens, W. Oyen, R. Liskamp and O. BoermanArticles
IJC
2007
605--610
[(18)F]FDG accumulation in an experimental model of multistage progression of cholangiocarcinoma
P. Laverman, W. Blokx, R. Te Morsche, C. Frielink, O. Boerman, W. Oyen and J. DrenthArticles
Hepatol Res
2007
127--132
Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides
I. Dijkgraaf, J. Kruijtzer, S. Liu, A. Soede, W. Oyen, F. Corstens, R. Liskamp and O. BoermanArticles
EJNMMI
2007
267--273
Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide
I. Dijkgraaf, S. Liu, J. Kruijtzer, A. Soede, W. Oyen, R. Liskamp, F. Corstens and O. BoermanArticles
NUCMB
2007
29--35
Synthesis of DOTA-conjugated multivalent cyclic-RGD peptide dendrimers via 1,3-dipolar cycloaddition and their biological evaluation: implications for tumor targeting and tumor imaging purposes
I. Dijkgraaf, A. Rijnders, A. Soede, A. Dechesne, G. van Esse, A. Brouwer, F. Corstens, O. Boerman, D. Rijkers and R. LiskampArticles
Org Biomol Chem
2007
935--944
FDG-PET/CT can visualise the extent of inflammation in rheumatoid arthritis of the tarsus
W. Vogel, P. van Riel and W. OyenArticles
EJNMMI
2007
439
Cushing's syndrome and bone mineral density: lowest Z scores in young patients
A. van der Eerden, M. den Heijer, W. Oyen and A. HermusArticles
NETHJM
2007
137--141
Enzymosomes with surface-exposed superoxide dismutase: in vivo behaviour and therapeutic activity in a model of adjuvant arthritis
M. Gaspar, O. Boerman, P. Laverman, M. Corvo, G. Storm and M. CruzArticles
JCONREL
2007
186--195
Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytes
J. Geelen, T. van der Velden, D. Te Loo, O. Boerman, L. van den Heuvel and L. MonnensArticles
NDT
2007
749--755
[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma
A. Wicki, D. Wild, D. Storch, C. Seemayer, M. Gotthardt, M. Behe, S. Kneifel, M. Mihatsch, J. Reubi, H. Mäcke and G. ChristoforiArticles
CLINCR
2007
3696--3705
The role of FDG-PET in the selection of patients with colorectal liver metastases
B. Wiering, P. Krabbe, H. Dekker, W. Oyen and T. RuersArticles
AOSO
2007
771--779
Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery
B. Wiering, T. Ruers, P. Krabbe, H. Dekker and W. OyenArticles
AOSO
2007
818--826